Arrowstreet Capital Limited Partnership boosted its holdings in AdvanSix Inc. (NYSE:ASIX – Free Report) by 441.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 219,310 shares of the company’s stock after acquiring an additional 178,843 shares during the quarter. Arrowstreet Capital Limited Partnership owned 0.82% of AdvanSix worth $6,248,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in the business. FMR LLC raised its position in shares of AdvanSix by 86.2% during the 3rd quarter. FMR LLC now owns 565,982 shares of the company’s stock worth $17,195,000 after buying an additional 261,964 shares in the last quarter. BNP Paribas Financial Markets increased its stake in shares of AdvanSix by 120.0% during the third quarter. BNP Paribas Financial Markets now owns 18,855 shares of the company’s stock valued at $573,000 after acquiring an additional 10,284 shares during the period. Centiva Capital LP bought a new stake in AdvanSix during the third quarter worth approximately $315,000. Quadrature Capital Ltd acquired a new stake in AdvanSix in the third quarter worth approximately $204,000. Finally, Wellington Management Group LLP boosted its stake in AdvanSix by 48.6% during the 3rd quarter. Wellington Management Group LLP now owns 469,685 shares of the company’s stock valued at $14,269,000 after purchasing an additional 153,686 shares in the last quarter. Institutional investors own 86.39% of the company’s stock.
Insider Activity
In other news, SVP Achilles B. Kintiroglou sold 4,000 shares of the company’s stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $22.24, for a total value of $88,960.00. Following the transaction, the senior vice president now owns 36,363 shares in the company, valued at $808,713.12. This represents a 9.91 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Erin N. Kane sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $30.19, for a total transaction of $150,950.00. Following the sale, the chief executive officer now owns 502,795 shares of the company’s stock, valued at approximately $15,179,381.05. This represents a 0.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 5.60% of the company’s stock.
AdvanSix Trading Down 5.7 %
AdvanSix (NYSE:ASIX – Get Free Report) last released its earnings results on Friday, February 21st. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.40. AdvanSix had a net margin of 2.91% and a return on equity of 6.26%. The business had revenue of $329.06 million for the quarter, compared to the consensus estimate of $377.15 million. Sell-side analysts predict that AdvanSix Inc. will post 4 EPS for the current year.
AdvanSix Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, March 24th. Shareholders of record on Monday, March 10th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 3.33%. The ex-dividend date of this dividend was Monday, March 10th. AdvanSix’s dividend payout ratio (DPR) is currently 39.75%.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on the company. UBS Group set a $35.00 price objective on AdvanSix in a research note on Tuesday, March 18th. StockNews.com downgraded shares of AdvanSix from a “buy” rating to a “hold” rating in a report on Monday, March 24th. Finally, Piper Sandler cut shares of AdvanSix from an “overweight” rating to a “neutral” rating and lowered their price objective for the stock from $35.00 to $26.00 in a research note on Monday.
View Our Latest Stock Analysis on ASIX
About AdvanSix
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Stories
- Five stocks we like better than AdvanSix
- How to Use the MarketBeat Excel Dividend Calculator
- Options Activity Points to More Volatility for Palantir Stock
- How to Choose Top Rated Stocks
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- What is the Australian Securities Exchange (ASX)
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.